Related Experiment Video
Updated: Aug 12, 2026

04:15
A Mouse Model of Fatigue Induced by Peripheral Irradiation
Published on: March 17, 2017
Vomiting associated with whole body irradiation
Clinical Radiology
|May 1, 1987
Summary
Vomiting after total body irradiation (TBI) often starts at 2-3 Gy and can recur. Sedation and limiting patient movement reduce TBI-induced vomiting incidence.
Area of Science:
- Oncology
- Radiation Oncology
- Clinical Medicine
Background:
- Bone marrow transplantation (BMT) frequently involves total body irradiation (TBI).
- Nausea and vomiting are common side effects of TBI.
- Understanding TBI-induced vomiting patterns is crucial for patient care.
Purpose of the Study:
- To investigate the patterns and influencing factors of vomiting in patients undergoing TBI before BMT.
- To identify thresholds for TBI dose triggering vomiting.
- To explore methods for reducing the incidence of TBI-induced vomiting.
Main Methods:
- Observational study of 305 patients undergoing TBI prior to BMT.
- Dose monitoring and recording of vomiting episodes.
- Analysis of patient factors (age, anxiety) and interventions (sedation, movement limitation).
Main Results:
- Vomiting typically begins after 2-3 Gy TBI, persisting up to 12 hours, with recurrence at 2-5 days.
- Fractionated radiation (<2 Gy fractions) showed infrequent vomiting, unrelated to cumulative dose beyond a threshold.
- Reduced incidence observed with patient movement limitation and adequate sedation; increased with anxiety. Higher incidence in patients aged 10-40.
Conclusions:
- Vomiting following TBI is dose-dependent up to a threshold and influenced by patient factors and interventions.
- Sedation and minimizing patient movement are effective in reducing TBI-induced vomiting.
- Complete prevention of vomiting is achievable in 50% of patients, suggesting potential for optimized antiemetic strategies.
Related Concept Videos
Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
Absorption of Radiation
The rate of heat transfer by emitted radiation is described by the Stefan-Boltzmann law of radiation:
Pathophysiology of Vomiting
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...

